trial · primary record
Intralipid, 20% Intravenous Emulsion
Obesity
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2026-06-01 |
| Primary endpoint | Change in brain glucose transport capacity |
| Registry ID | NCT04328337 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:47.589Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04328337
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.